Navigation Links
Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease
Date:3/27/2009

NEW YORK, March 27 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced that it has awarded approximately $2.1 million total to seven research teams working to improve drug delivery for Parkinson's disease.

The funding was awarded under the Foundation's Improving Delivery of Parkinson's Disease Therapeutics to the Brain. The program is designed to address two major challenges to the development of transformative treatments for Parkinson's disease: the need for non-invasive drug delivery technologies allowing therapeutics to cross the blood-brain barrier, and the need to more precisely understand how molecules move inside the central nervous system in order to target treatments to specific regions of the brain.

Funded projects are listed below. Full information on funded projects, including grant abstracts and researcher bios, is available on the Foundation's Searchable Database of Funded Grants.

Image-guided Gene Delivery for Parkinson's

Krysztof Bankiewicz, M.D., Ph.D., University of California, San Francisco

Convection Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Human Parkinson's Disease

Jeff Elias, M.D., University of Virginia, and Russell Lonser, M.D., National Institute of Neurodegenerative Disease and Stroke

Real-time Monitoring of Targeting, Delivery, and Spread of Therapeutic Agents in the Brain

Samir Jafri, Ph.D., University of Maryland, Baltimore, and Cha-Min Tang, M.D., Ph.D., University of Maryland School of Medicine

Utilizing Novel Tracers to Determine the Distribution of Therapeutic Agents In Vivo

RamakrishnaVenugopalan, Ph.D., Codman and Shurtleff, Inc.

'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
5. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
8. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
9. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
10. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
11. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  Amgen (NASDAQ: ... Novartis in the areas of Alzheimer,s disease and ... Alzheimer,s disease by teaming up with Novartis on ... directed at genetically predisposed individuals at risk of ... focus on the commercialization of its migraine programs ...
(Date:9/1/2015)... VERONA, Va. , Sept. 1, 2015  AccuTec ... Care Company,s (EPC) Industrial Blades division.  EPC announced in ... operations in Verona, Virginia and ... the completion of the sale process. ... Executive Officer of AccuTec Blades said, "Our new name, ...
(Date:9/1/2015)... Mass. and OR YEHUDA, Israel ... Inc . (Nasdaq: HTWR ), a leading innovator ... revolutionizing the treatment of advanced heart failure, announced today ... acquire Valtech Cardio, Ltd . ("Valtech").  Valtech is ... of innovative surgical and transcatheter valve repair and replacement ...
Breaking Medicine Technology:Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10
... Dec. 12, 2011  Daiichi Sankyo Company, Limited (hereafter, Daiichi ... showing that edoxaban, a direct oral once-daily Factor Xa ... (VTE) following total knee or hip arthroplasty, when compared ... of a composite of deep vein thrombosis (DVT) and ...
... Dec. 12, 2011 Boston Scientific Corporation (NYSE: ... Charger™ PTA Balloon Catheter, a 0.035" percutaneous transluminal angioplasty ... peripheral angioplasty procedures.  The Charger PTA Balloon Catheter is ... 2011 and strengthens the Company,s position as a global ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5Boston Scientific Launches Charger™ PTA Balloon Catheter 2Boston Scientific Launches Charger™ PTA Balloon Catheter 3Boston Scientific Launches Charger™ PTA Balloon Catheter 4
(Date:9/1/2015)... , ... September 02, 2015 , ... The Journal ... quality of life, in the USA ”. , As corresponding author Mr Christopher Malone ... United States. In our study, we endeavoured to better understand how migraine headaches impact ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy , ... partnership with Apex Physical Therapy (Apex) is official as of August ... compassionate, and empathetic care to local residents from their combined eight locations throughout ...
(Date:9/1/2015)... ... September 01, 2015 , ... Celebrity hairstylist and Beauty ... “The Beauty Behind the Fashion” on Thursday, Oct. 1, at the La Valencia ... the spotlight on the collaboration between fashion and professional hair, makeup and nail design. ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Horizon Blue ... the 50 Best Companies for Latinas in the LATINA Style 50 Report that recognizes ... , For 2015, Horizon BCBSNJ climbs from number 24 to 21 ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer ... for Dermatologic Surgery, according to a new survey that also offers insight on ... Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings for ...
Breaking Medicine News(10 mins):Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3
... can become,overwhelming by its seemingly endless challenges when it ... there is a steady upward,trend of dads or moms ... to ensure that this role reversal is a positive ... Therapists offers the,following tips for fathers or mothers who ...
... Researchers have found surprising evidence that an antidepressant ... antipsychotic (risperidone) in the alleviation of severe agitation ... that the antidepressant was associated with significantly lower ... the online American Journal of Geriatric Psychiatry (in ...
... women, breast cancer survivors reported more days of fatigue ... the October 15, 2007 issue of CANCER, a peer-reviewed ... received both chemotherapy and radiotherapy reported the most severe ... in the general population and, anecdotally, common among cancer ...
... Believe Today,s Teens Face Greater Worries ... ... The Partnership for a Drug-Free,America(R), in collaboration with MetLife Foundation, today ... play in,the lives of their grandchildren. Released today, Grandparent,s Day, the,survey ...
... Percent of Pain Care Professionals Polled during PAINWeek 2007 ... Pain Also Suffer from Insomnia, LAS VEGAS, Sept. ... and insomnia, the polled health care professionals surveyed,during PAINWeek ... will relieve the intensity of pain. Nearly 98 ...
... DTI Medical Corporation,(Pink Sheets: DTIM) announced and publicly-noticed its shareholders that ... its Board of,Directors to affect a name change. Questions regarding the ... &,Transfer Company, Inc., Draper, Utah. Notice of the intended and pending,corporate ... ...
Cached Medicine News:Health News:Stay-At-Home Parenting: How to Juggle the Responsibilities 2Health News:Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia 2Health News:Chemotherapy may be culprit for fatigue in breast cancer survivors 2Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 2Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 3Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 4Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 2Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 3Health News:DTI Medical Corporation Announces Reverse Split and Other Corporate Developments 2
... is the least expensive of the series. It has ... central area of the cornea. The model comes with ... a picture of a patients corneal endothelium, you simply ... on the chin rest. The left side of the ...
... Orthokeratology (oprifocon A) Contact Lenses ... lenses used for orthokeratology, a ... (myopia). The patient wears these ... in the morning. During the ...
... These are rigid gas permeable contact lenses ... that temporarily corrects nearsightedness (myopia). The patient ... removes them upon wakening. During the day, ... Paragon CRT and Quadra RG contact lenses ...
... Looking for a way to help your ... cardiovascular disease? Based on the outcomes ... Counterpulsation (ECP) has improved the quality of ... perform normal activities of daily living. , ...
Medicine Products: